| Dr Leah Ann Dvorak, DO | |
|
301 Becker Avenue Sw, Willmar, MN 56201-3302 | |
| (320) 235-4574 | |
| (320) 231-4503 |
| Full Name | Dr Leah Ann Dvorak |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 15 Years |
| Location | 301 Becker Avenue Sw, Willmar, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144457466 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 55888 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carris Health Llc | Willmar, MN | Hospital |
| Chippewa County Hospital | Montevideo, MN | Hospital |
| Meeker Memorial Hospital | Litchfield, MN | Hospital |
| Carris Health - Redwood, Llc | Redwood falls, MN | Hospital |
| Johnson Memorial Hospital | Dawson, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minnesota Pathologists, Chartered | 7911003835 | 4 |
News Archive
Masimo announced today that its Board of Directors has declared a special $0.75 per share cash dividend, payable on December 21, 2010 to stockholders of record as of the close of business on December 7, 2010. The total dividend payout is expected to be approximately $44.3 million, based on the current shares outstanding and will be the third instance of a special dividend paid by Masimo in the past four years.
Re-routing anti-cancer drugs to the "power plants" that make energy to keep cells alive is a promising but long-neglected approach to preventing emergence of the drug-resistant forms of cancer - source of a serious medical problem, scientists are reporting.
MarketResearch.com has announced the addition of Kalorama Information's new report "The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)," to their collection of Healthcare market reports.
Recent work, in particular the CAMERA study, has used MRI to study the brains of migraine sufferers and has shown that a higher proportion of these patients exhibit lesions of the brain microvessels than the rest of the population.
The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.
› Verified 8 days ago
| Entity Name | Douglas County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164424305 PECOS PAC ID: 0648171413 Enrollment ID: O20040115000387 |
News Archive
Masimo announced today that its Board of Directors has declared a special $0.75 per share cash dividend, payable on December 21, 2010 to stockholders of record as of the close of business on December 7, 2010. The total dividend payout is expected to be approximately $44.3 million, based on the current shares outstanding and will be the third instance of a special dividend paid by Masimo in the past four years.
Re-routing anti-cancer drugs to the "power plants" that make energy to keep cells alive is a promising but long-neglected approach to preventing emergence of the drug-resistant forms of cancer - source of a serious medical problem, scientists are reporting.
MarketResearch.com has announced the addition of Kalorama Information's new report "The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)," to their collection of Healthcare market reports.
Recent work, in particular the CAMERA study, has used MRI to study the brains of migraine sufferers and has shown that a higher proportion of these patients exhibit lesions of the brain microvessels than the rest of the population.
The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.
› Verified 8 days ago
| Entity Name | Minnesota Pathologists, Chartered |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992851315 PECOS PAC ID: 7911003835 Enrollment ID: O20070509000225 |
News Archive
Masimo announced today that its Board of Directors has declared a special $0.75 per share cash dividend, payable on December 21, 2010 to stockholders of record as of the close of business on December 7, 2010. The total dividend payout is expected to be approximately $44.3 million, based on the current shares outstanding and will be the third instance of a special dividend paid by Masimo in the past four years.
Re-routing anti-cancer drugs to the "power plants" that make energy to keep cells alive is a promising but long-neglected approach to preventing emergence of the drug-resistant forms of cancer - source of a serious medical problem, scientists are reporting.
MarketResearch.com has announced the addition of Kalorama Information's new report "The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)," to their collection of Healthcare market reports.
Recent work, in particular the CAMERA study, has used MRI to study the brains of migraine sufferers and has shown that a higher proportion of these patients exhibit lesions of the brain microvessels than the rest of the population.
The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leah Ann Dvorak, DO 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Dr Leah Ann Dvorak, DO 301 Becker Avenue Sw, Willmar, MN 56201-3302 Ph: (320) 235-4574 |
News Archive
Masimo announced today that its Board of Directors has declared a special $0.75 per share cash dividend, payable on December 21, 2010 to stockholders of record as of the close of business on December 7, 2010. The total dividend payout is expected to be approximately $44.3 million, based on the current shares outstanding and will be the third instance of a special dividend paid by Masimo in the past four years.
Re-routing anti-cancer drugs to the "power plants" that make energy to keep cells alive is a promising but long-neglected approach to preventing emergence of the drug-resistant forms of cancer - source of a serious medical problem, scientists are reporting.
MarketResearch.com has announced the addition of Kalorama Information's new report "The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)," to their collection of Healthcare market reports.
Recent work, in particular the CAMERA study, has used MRI to study the brains of migraine sufferers and has shown that a higher proportion of these patients exhibit lesions of the brain microvessels than the rest of the population.
The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.
› Verified 8 days ago
Steven Michael Vanderwerf, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 301 Becker Ave Sw, Willmar, MN 56201 Phone: 320-231-4500 | |
Lee L. Cafferty, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 301 Becker Ave Sw, Willmar, MN 56201 Phone: 320-231-4500 | |
Dr. Patricia M Hoeft, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 301 Becker Ave Sw, Willmar, MN 56201 Phone: 320-231-4500 Fax: 320-231-4503 | |
Sharon H. Banister, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 301 Becker Ave Sw, Rice Memorial Hospital, Willmar, MN 56201 Phone: 320-231-4500 Fax: 320-231-4861 | |
Raquel Kay Walsh Jahnke, DO, MBA Pathology Medicare: Accepting Medicare Assignments Practice Location: 301 Becker Ave Sw, Willmar, MN 56201 Phone: 320-235-4543 |